@article{5a235023c6ec4f488b8e6764b9b3fb7a,
title = "Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma",
abstract = "To investigate the role of health-related quality of life (HRQoL) at randomization as independent prognostic factors for survival and time to failure, and to explore associations between HRQoL and treatment effects.",
keywords = "Adolescent, Adult, Aged, Antineoplastic Agents, Chemotherapy, Adjuvant, Disease-Free Survival, Dose-Response Relationship, Drug, Female, Humans, Interferons, Male, Melanoma, Middle Aged, Prognosis, Quality of Life, Questionnaires, Skin Neoplasms, Young Adult",
author = "Yvonne Brandberg and Hemming Johansson and Steinar Aamdal and Lars Bastholt and Michaela Hernberg and Ulrika Stierner and {von der Maase}, Hans and Johan Hansson and {Nordic Melanoma Cooperative Group}",
year = "2013",
month = aug,
doi = "10.3109/0284186X.2013.789140",
language = "English",
volume = "52",
pages = "1086--93",
journal = "Acta oncologica ",
issn = "0284-186X",
publisher = "Medical Journals Sweden AB",
number = "6",
}